• Something wrong with this record ?

Adherence to application technique of inhaled corticosteroid in patients with asthma and COVID-19 improves outcomes

A. Tichopád, J. Žigmond, M. Jeseňák, I. Solovič, K. Breciková, M. Rybář, M. Rožánek, V. Sedlák

. 2024 ; 11 (1) : . [pub] 20240106

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Inhaled corticosteroids have been widely reported as a preventive measure against the development of severe forms of COVID-19 not only in patients with asthma. METHODS: In 654 Czech and Slovak patients with asthma who developed COVID-19, we investigated whether the correct use of inhaler containing corticosteroids was associated with a less severe course of COVID-19 and whether this had an impact on the need for hospitalisation, measurable lung functions and quality of life (QoL). RESULTS: Of the studied cohort 51.4% had moderate persistent, 29.9% mild persistent and 7.2% severe persistent asthma. We found a significant adverse effect of poor inhaler adherence on COVID-19 severity (p=0.049). We also observed a lower hospitalisation rate in patients adequately taking the inhaler with OR of 0.83. Vital capacity and forced expiratory lung volume deterioration caused by COVID-19 were significantly reversed, by approximately twofold to threefold, in individuals who inhaled correctly. CONCLUSION: Higher quality of inhalation technique of corticosteroids measured by adherence to an inhaled medication application technique (A-AppIT) score had a significant positive effect on reversal of the vital capacity and forced expiratory lung volume in 1 s worsening (p=0.027 and p<0.0001, respectively) due to COVID-19. Scoring higher in the A-AppIT was also associated with significantly improved QoL. All measured variables concordantly and without exception showed a positive improvement in response to better adherence. We suggest that corticosteroids provide protection against the worsening of lungs in patients with COVID-19 and that correct and easily assessable adherence to corticosteroids with appropriate inhalation technique play an important role in preventing severe form of COVID-19.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007640
003      
CZ-PrNML
005      
20241127145556.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmjresp-2023-001874 $2 doi
035    __
$a (PubMed)38184317
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Tichopád, Aleš $u Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic $1 https://orcid.org/0000000213080877 $7 xx0305052
245    10
$a Adherence to application technique of inhaled corticosteroid in patients with asthma and COVID-19 improves outcomes / $c A. Tichopád, J. Žigmond, M. Jeseňák, I. Solovič, K. Breciková, M. Rybář, M. Rožánek, V. Sedlák
520    9_
$a BACKGROUND: Inhaled corticosteroids have been widely reported as a preventive measure against the development of severe forms of COVID-19 not only in patients with asthma. METHODS: In 654 Czech and Slovak patients with asthma who developed COVID-19, we investigated whether the correct use of inhaler containing corticosteroids was associated with a less severe course of COVID-19 and whether this had an impact on the need for hospitalisation, measurable lung functions and quality of life (QoL). RESULTS: Of the studied cohort 51.4% had moderate persistent, 29.9% mild persistent and 7.2% severe persistent asthma. We found a significant adverse effect of poor inhaler adherence on COVID-19 severity (p=0.049). We also observed a lower hospitalisation rate in patients adequately taking the inhaler with OR of 0.83. Vital capacity and forced expiratory lung volume deterioration caused by COVID-19 were significantly reversed, by approximately twofold to threefold, in individuals who inhaled correctly. CONCLUSION: Higher quality of inhalation technique of corticosteroids measured by adherence to an inhaled medication application technique (A-AppIT) score had a significant positive effect on reversal of the vital capacity and forced expiratory lung volume in 1 s worsening (p=0.027 and p<0.0001, respectively) due to COVID-19. Scoring higher in the A-AppIT was also associated with significantly improved QoL. All measured variables concordantly and without exception showed a positive improvement in response to better adherence. We suggest that corticosteroids provide protection against the worsening of lungs in patients with COVID-19 and that correct and easily assessable adherence to corticosteroids with appropriate inhalation technique play an important role in preventing severe form of COVID-19.
650    _2
$a lidé $7 D006801
650    _2
$a kvalita života $7 D011788
650    12
$a COVID-19 $7 D000086382
650    12
$a bronchiální astma $x farmakoterapie $7 D001249
650    _2
$a hormony kůry nadledvin $7 D000305
650    _2
$a usilovný výdechový objem $7 D005541
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Žigmond, Jan $u Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic
700    1_
$a Jeseňák, Miloš $u Department of Pulmonology and Phthisiology, Comenius University in Bratislava Jessenius Faculty of Medicine in Martin, Martin, Slovakia
700    1_
$a Solovič, Ivan $u National Institute of Tuberculosis, Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovakia, Vyšné Hágy, Slovakia, Vyšné Hágy, Slovakia $u Faculty of Health, Catholic University in Ruzomberok, Ruzomberok, Slovakia
700    1_
$a Lejavová, Katarína, $u CEEOR spol. s.r.o, Prague, Czech Republic $d 1987- $7 xx0326522
700    1_
$a Rybář, Marian $u Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic
700    1_
$a Rožánek, Martin $u Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic
700    1_
$a Sedlák, Vratislav $u Department of Respiratory Medicine, Fakultní Nemocnice Hradec Králové, Hradec Králové, Czech Republic vratislav.sedlak@fnhk.cz
773    0_
$w MED00214731 $t BMJ open respiratory research $x 2052-4439 $g Roč. 11, č. 1 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38184317 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20241127145551 $b ABA008
999    __
$a ok $b bmc $g 2081559 $s 1217407
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 11 $c 1 $e 20240106 $i 2052-4439 $m BMJ open respiratory research $n BMJ Open Respir Res $x MED00214731
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...